190 related articles for article (PubMed ID: 3515118)
1. Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients.
Roti E; Braverman LE; Robuschi G; Salvi M; Gardini E; d'Amato L; Maestri D; Montermini M; Borciani E; Pezzarossa A
Metabolism; 1986 Apr; 35(4):337-42. PubMed ID: 3515118
[TBL] [Abstract][Full Text] [Related]
2. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism.
O'Meara NM; Blackman JD; Sturis J; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):79-84. PubMed ID: 8421108
[TBL] [Abstract][Full Text] [Related]
4. [Insulin, glucagon and growth hormone responses during glucose, arginine and insulin tolerance tests in children with hyperthyroidism].
Kato T; Matsuura N; Fujita H; Fujieda K; Nohara Y; Mikami Y; Abe K; Fukushima N
Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):665-76. PubMed ID: 3902521
[TBL] [Abstract][Full Text] [Related]
5. Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients.
Ikeda T; Fujiyama K; Hoshino T; Takeuchi T; Mashiba H; Tominaga M
Metabolism; 1990 Jun; 39(6):633-7. PubMed ID: 2191191
[TBL] [Abstract][Full Text] [Related]
6. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
[TBL] [Abstract][Full Text] [Related]
7. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients.
Osei K; Falko JM; O'Dorisio TM; Adam DR
Diabetes Care; 1984; 7(5):471-5. PubMed ID: 6389061
[TBL] [Abstract][Full Text] [Related]
8. Impaired pancreatic alpha-cell response in hyperthyroidism.
Kabadi UM; Eisenstein AB
J Clin Endocrinol Metab; 1980 Sep; 51(3):478-82. PubMed ID: 6997327
[TBL] [Abstract][Full Text] [Related]
9. Effect of the enteroinsular axis on both the A- and B-cell response to arginine after oral glucose in man.
Shimizu I; Hirota M; Ohboshi C; Mizuno A; Shima K
Diabetologia; 1987 Nov; 30(11):846-50. PubMed ID: 3328720
[TBL] [Abstract][Full Text] [Related]
10. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
11. The pancreatic alpha and beta cells responses to 1-arginine and insulin-induced hypoglycaemia in hyperthyroidism.
Shima K; Sawazaki N; Tanaka R; Morishita S; Tarui S
Acta Endocrinol (Copenh); 1976 Sep; 83(1):114-22. PubMed ID: 785921
[TBL] [Abstract][Full Text] [Related]
12. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of high-dose biosynthetic human C-peptide on pancreatic hormone release in normal subjects.
Wojcikowski C; Blackman J; Ostrega D; Lewis G; Galloway J; Rubenstein AH; Polonsky KS
Metabolism; 1990 Aug; 39(8):827-32. PubMed ID: 2198434
[TBL] [Abstract][Full Text] [Related]
14. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
15. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
16. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
Rickels MR; Mueller R; Markmann JF; Naji A
J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
[TBL] [Abstract][Full Text] [Related]
18. Insulin delivery rate in response to glucose and arginine infusion in hyperthyroidism.
Asano T; Okumura M
Diabetologia; 1982 Aug; 23(2):108-13. PubMed ID: 6751896
[TBL] [Abstract][Full Text] [Related]
19. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
Herman WH; Fajans SS; Smith MJ; Polonsky KS; Bell GI; Halter JB
Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretion and sensitivity in hyperthyroidism.
Jap TS; Ho LT; Won JG
Horm Metab Res; 1989 May; 21(5):261-6. PubMed ID: 2673961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
